Sumitomo Mitsui Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.2K Sell
1
-7
-88% -$7.15K ﹤0.01% 213
2026
Q1
$7.36K Sell
8
-222
-97% -$225K ﹤0.01% 186
2025
Q4
$248K Buy
230
+164
+248% +$157K ﹤0.01% 121
2025
Q3
$48K Buy
66
+31
+89% +$23.1K ﹤0.01% 148
2025
Q2
$27.1K Buy
+35
New +$27.2K ﹤0.01% 207
2024
Q3
Sell
-27
Closed -$24.5K 182
2024
Q2
$24.5K Buy
+27
New +$21.6K ﹤0.01% 162

Other funds holding LLY

Sumitomo Mitsui Financial Group's LLY Position: Q2 2026 in Review

Sumitomo Mitsui Financial Group reduced its Eli Lilly (LLY) stake by 88% in Q2 2026, selling an estimated $7.15K and leaving 1 share worth $1.2K. The position accounts for ﹤0.01% of the portfolio, ranked #213.

Sumitomo Mitsui Financial Group first reported a position in LLY in Q2 2024 and has held it in 6 quarters since. The position peaked at $248K in Q4 2025. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sumitomo Mitsui Financial Group held 1 share of Eli Lilly worth $1.2K as of Q2 2026.
  • Sumitomo Mitsui Financial Group sold 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up ﹤0.01% of Sumitomo Mitsui Financial Group's portfolio in Q2 2026, its #213 holding.
  • Sumitomo Mitsui Financial Group first reported a position in Eli Lilly in Q2 2024 and has held it in 6 quarters since.
  • Sumitomo Mitsui Financial Group's Eli Lilly position peaked at $248K in Q4 2025.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q2 2026, filed 13 Aug 2026.